Skip to main content
Erschienen in: Urolithiasis 6/2010

01.12.2010 | SYMPOSIUM PAPER

Nephrocalcinosis in animal models with and without stones

verfasst von: Saeed R. Khan

Erschienen in: Urolithiasis | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Nephrocalcinosis is the deposition of calcium salts in renal parenchyma and can be intratubular or interstitial. Animal model studies indicate that intratubular nephrocalcinosis is a result of increased urinary supersaturation. Urinary supersaturation with respect to calcium oxalate (CaOx) and calcium phosphate (CaP) are generally achieved at different locations in the renal tubules. As a result experimental induction of hyperoxaluria in animals with CaP deposits does not lead to growth of CaOx over CaP. Interstitial nephrocalcinosis has been seen in mice with lack of crystallization modulators Tamm–Horsfall protein and osteopontin. Sodium phosphate co-transporter or sodiumhydrogen exchanger regulator factor-1 null mice also produced interstitial nephrocalcinosis. Crystals plug the tubules by aggregating and attaching to the luminal cell surface. Structural features of the renal tubules also play a role in crystal retention. The crystals plugging the terminal collecting ducts when exposed to the metastable pelvic urine may promote the formation of stone.
Literatur
1.
Zurück zum Zitat Evan AP (2010) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25(5):831–841CrossRefPubMed Evan AP (2010) Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 25(5):831–841CrossRefPubMed
3.
Zurück zum Zitat Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol 158:2062CrossRefPubMed Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol 158:2062CrossRefPubMed
4.
Zurück zum Zitat Low RK, Stoller ML, Schreiber CK (2000) Metabolic and urinary risk factors associated with Randall’s papillary plaques. J Endourol 14:507CrossRefPubMed Low RK, Stoller ML, Schreiber CK (2000) Metabolic and urinary risk factors associated with Randall’s papillary plaques. J Endourol 14:507CrossRefPubMed
5.
Zurück zum Zitat Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 156:1263CrossRefPubMed Stoller ML, Low RK, Shami GS et al (1996) High resolution radiography of cadaveric kidneys: unraveling the mystery of Randall’s plaque formation. J Urol 156:1263CrossRefPubMed
6.
Zurück zum Zitat Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227CrossRefPubMed Evan AP, Coe FL, Lingeman JE et al (2006) Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 69:2227CrossRefPubMed
7.
Zurück zum Zitat Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795CrossRefPubMed Evan AP, Lingeman J, Coe F et al (2007) Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 71:795CrossRefPubMed
8.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576CrossRefPubMed Evan AP, Lingeman JE, Coe FL et al (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576CrossRefPubMed
9.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111CrossRefPubMed Evan AP, Lingeman JE, Coe FL et al (2008) Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol 28:111CrossRefPubMed
10.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607PubMed Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607PubMed
11.
Zurück zum Zitat Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325 Evan AP, Coe FL, Gillen D et al (2008) Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291:325
12.
Zurück zum Zitat Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194CrossRefPubMed Khan SR, Finlayson B, Hackett R (1984) Renal papillary changes in patient with calcium oxalate lithiasis. Urology 23:194CrossRefPubMed
13.
Zurück zum Zitat Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604PubMed Asplin JR, Mandel NS, Coe FL (1996) Evidence of calcium phosphate supersaturation in the loop of Henle. Am J Physiol 270:F604PubMed
14.
15.
16.
Zurück zum Zitat McMartin K (2009) Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? Clin Toxicol (Phila) 47:859 McMartin K (2009) Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? Clin Toxicol (Phila) 47:859
17.
Zurück zum Zitat Khan SR, Finlayson B, Hackett RL (1979) Histologic study of the early events in oxalate induced intranephronic calculosis. Invest Urol 17:199PubMed Khan SR, Finlayson B, Hackett RL (1979) Histologic study of the early events in oxalate induced intranephronic calculosis. Invest Urol 17:199PubMed
18.
Zurück zum Zitat Khan SR, Finlayson B, Hackett RL (1982) Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla. Am J Pathol 107:59PubMed Khan SR, Finlayson B, Hackett RL (1982) Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla. Am J Pathol 107:59PubMed
19.
Zurück zum Zitat Khan SR, Hackett RL (1991) Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:707PubMed Khan SR, Hackett RL (1991) Retention of calcium oxalate crystals in renal tubules. Scanning Microsc 5:707PubMed
20.
Zurück zum Zitat Khan SR, Finlayson B, Hackett RL (1983) Experimental induction of crystalluria in rats using mini-osmotic pumps. Urol Res 11:199CrossRefPubMed Khan SR, Finlayson B, Hackett RL (1983) Experimental induction of crystalluria in rats using mini-osmotic pumps. Urol Res 11:199CrossRefPubMed
21.
Zurück zum Zitat Marengo SR, Chen DH, Evan AP et al (2006) Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis. Urol Res 34:200CrossRefPubMed Marengo SR, Chen DH, Evan AP et al (2006) Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis. Urol Res 34:200CrossRefPubMed
22.
Zurück zum Zitat Marengo SR, Zhang A, Traverso EJ (2008) Partitioning of 14C-oxalate excretion in rats during a persistent oxalate challenge. Urol Res 36:319CrossRefPubMed Marengo SR, Zhang A, Traverso EJ (2008) Partitioning of 14C-oxalate excretion in rats during a persistent oxalate challenge. Urol Res 36:319CrossRefPubMed
23.
Zurück zum Zitat Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914CrossRefPubMed Khan SR, Glenton PA, Byer KJ (2006) Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-l-proline. Kidney Int 70:914CrossRefPubMed
24.
Zurück zum Zitat de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats I. Can this be a model for human stone formation? Scanning Microsc 9:103PubMed de Bruijn WC, Boeve ER, van Run PR et al (1995) Etiology of calcium oxalate nephrolithiasis in rats I. Can this be a model for human stone formation? Scanning Microsc 9:103PubMed
25.
Zurück zum Zitat de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761CrossRefPubMed de Water R, Noordermeer C, van der Kwast TH et al (1999) Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis 33:761CrossRefPubMed
26.
Zurück zum Zitat Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226PubMed Khan SR, Shevock PN, Hackett RL (1992) Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis. J Urol 147:226PubMed
27.
Zurück zum Zitat Khan SR, Thamilselvan S (2000) Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4:305PubMed Khan SR, Thamilselvan S (2000) Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals. Mol Urol 4:305PubMed
28.
Zurück zum Zitat Khan SR, Shevock PN, Hackett RL (1989) Urinary enzymes and calcium oxalate urolithiasis. J Urol 142:846PubMed Khan SR, Shevock PN, Hackett RL (1989) Urinary enzymes and calcium oxalate urolithiasis. J Urol 142:846PubMed
29.
Zurück zum Zitat Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059CrossRefPubMed Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059CrossRefPubMed
30.
Zurück zum Zitat Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117CrossRefPubMed Thamilselvan S, Menon M (2005) Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96:117CrossRefPubMed
31.
Zurück zum Zitat Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75CrossRefPubMed Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75CrossRefPubMed
32.
Zurück zum Zitat Toblli JE, Ferder L, Stella I et al (2002) Enalapril prevents fatty liver in nephrotic rats. J Nephrol 15:358PubMed Toblli JE, Ferder L, Stella I et al (2002) Enalapril prevents fatty liver in nephrotic rats. J Nephrol 15:358PubMed
33.
Zurück zum Zitat Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550CrossRefPubMed Toblli JE, Ferder L, Stella I et al (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168:1550CrossRefPubMed
34.
Zurück zum Zitat Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635CrossRefPubMed Umekawa T, Hatanaka Y, Kurita T et al (2004) Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys. J Am Soc Nephrol 15:635CrossRefPubMed
35.
36.
Zurück zum Zitat Gokhale JA, Glenton PA, Khan SR (1996) Localization of Tamm–Horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron 73:456CrossRefPubMed Gokhale JA, Glenton PA, Khan SR (1996) Localization of Tamm–Horsfall protein and osteopontin in a rat nephrolithiasis model. Nephron 73:456CrossRefPubMed
37.
Zurück zum Zitat Gokhale JA, Glenton PA, Khan SR (1997) Biochemical and quantitative analysis of Tamm–Horsfall protein in rats. Urol Res 25:347CrossRefPubMed Gokhale JA, Glenton PA, Khan SR (1997) Biochemical and quantitative analysis of Tamm–Horsfall protein in rats. Urol Res 25:347CrossRefPubMed
38.
Zurück zum Zitat Marengo SR, Chen DH, Kaung HL et al (2002) Decreased renal expression of the putative calcium oxalate inhibitor Tamm–Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167:2192CrossRefPubMed Marengo SR, Chen DH, Kaung HL et al (2002) Decreased renal expression of the putative calcium oxalate inhibitor Tamm–Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167:2192CrossRefPubMed
39.
Zurück zum Zitat Katsuma S, Shiojima S, Hirasawa A et al (2002) Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 296:544CrossRefPubMed Katsuma S, Shiojima S, Hirasawa A et al (2002) Global analysis of differentially expressed genes during progression of calcium oxalate nephrolithiasis. Biochem Biophys Res Commun 296:544CrossRefPubMed
40.
Zurück zum Zitat Khan SR, Johnson JM, Peck AB et al (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173CrossRefPubMed Khan SR, Johnson JM, Peck AB et al (2002) Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis. J Urol 168:1173CrossRefPubMed
41.
Zurück zum Zitat Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408PubMed Suzuki K, Tanaka T, Miyazawa K et al (1999) Gene expression of prothrombin in human and rat kidneys: basic and clinical approach. J Am Soc Nephrol 10(Suppl 14):S408PubMed
42.
Zurück zum Zitat Iida S, Inoue M, Yoshii S et al (1999) Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10(Suppl 14):S412PubMed Iida S, Inoue M, Yoshii S et al (1999) Molecular detection of heparan sulfate proteoglycan mRNA in rat kidney during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10(Suppl 14):S412PubMed
43.
Zurück zum Zitat Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687CrossRefPubMed Moriyama MT, Glenton PA, Khan SR (2001) Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J Urol 165:1687CrossRefPubMed
44.
Zurück zum Zitat Mandel NS, Henderson JD Jr, Hung LY et al (2004) A porcine model of calcium oxalate kidney stone disease. J Urol 171:1301CrossRefPubMed Mandel NS, Henderson JD Jr, Hung LY et al (2004) A porcine model of calcium oxalate kidney stone disease. J Urol 171:1301CrossRefPubMed
45.
Zurück zum Zitat Kaplon DM, Penniston KL, Darriet C et al (2010) Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model. J Endourol 24(3):355–359CrossRefPubMed Kaplon DM, Penniston KL, Darriet C et al (2010) Hydroxyproline-induced hyperoxaluria using acidified and traditional diets in the porcine model. J Endourol 24(3):355–359CrossRefPubMed
46.
Zurück zum Zitat Mo L, Liaw L, Evan AP et al (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm–Horsfall protein, or both. Am J Physiol Renal Physiol 293:F1935CrossRefPubMed Mo L, Liaw L, Evan AP et al (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm–Horsfall protein, or both. Am J Physiol Renal Physiol 293:F1935CrossRefPubMed
47.
Zurück zum Zitat Wesson JA, Johnson RJ, Mazzali M et al (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139CrossRefPubMed Wesson JA, Johnson RJ, Mazzali M et al (2003) Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139CrossRefPubMed
48.
Zurück zum Zitat Okada A, Nomura S, Higashibata Y et al (2007) Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res 35:89CrossRefPubMed Okada A, Nomura S, Higashibata Y et al (2007) Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol Res 35:89CrossRefPubMed
49.
Zurück zum Zitat Okada A, Yasui T, Hamamoto S et al (2009) Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res 24:908CrossRefPubMed Okada A, Yasui T, Hamamoto S et al (2009) Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res 24:908CrossRefPubMed
50.
Zurück zum Zitat Khan SR, Glenton PA (2008) Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter. Am J Physiol Renal Physiol 294:F1109CrossRefPubMed Khan SR, Glenton PA (2008) Calcium oxalate crystal deposition in kidneys of hypercalciuric mice with disrupted type IIa sodium-phosphate cotransporter. Am J Physiol Renal Physiol 294:F1109CrossRefPubMed
51.
Zurück zum Zitat Bushinsky DA, Frick KK, Nehrke K (2006) Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 15:403CrossRefPubMed Bushinsky DA, Frick KK, Nehrke K (2006) Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 15:403CrossRefPubMed
52.
Zurück zum Zitat Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57:550CrossRefPubMed Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57:550CrossRefPubMed
53.
Zurück zum Zitat Bushinsky DA, Grynpas MD, Asplin JR (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59:1415CrossRefPubMed Bushinsky DA, Grynpas MD, Asplin JR (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59:1415CrossRefPubMed
54.
Zurück zum Zitat Bushinsky DA, Asplin JR, Grynpas MD et al (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975CrossRefPubMed Bushinsky DA, Asplin JR, Grynpas MD et al (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975CrossRefPubMed
55.
Zurück zum Zitat Okamoto N, Aruga S, Tomita K et al (2007) Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3. Int J Urol 14:60CrossRefPubMed Okamoto N, Aruga S, Tomita K et al (2007) Chronic acid ingestion promotes renal stone formation in rats treated with vitamin D3. Int J Urol 14:60CrossRefPubMed
56.
Zurück zum Zitat Khan SR, Glenton PA (1995) Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. J Urol 153:811CrossRefPubMed Khan SR, Glenton PA (1995) Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. J Urol 153:811CrossRefPubMed
57.
Zurück zum Zitat Hennequin C, Tardivel S, Medetognon J et al (1998) A stable animal model of diet-induced calcium oxalate crystalluria. Urol Res 26:57CrossRefPubMed Hennequin C, Tardivel S, Medetognon J et al (1998) A stable animal model of diet-induced calcium oxalate crystalluria. Urol Res 26:57CrossRefPubMed
58.
Zurück zum Zitat Serafini-Cessi F, Malagolini N, Cavallone D (2003) Tamm–Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42:658CrossRefPubMed Serafini-Cessi F, Malagolini N, Cavallone D (2003) Tamm–Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42:658CrossRefPubMed
59.
Zurück zum Zitat Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201CrossRefPubMed Atmani F, Glenton PA, Khan SR (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201CrossRefPubMed
60.
Zurück zum Zitat Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99PubMed Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99PubMed
61.
Zurück zum Zitat Glauser A, Hochreiter W, Jaeger P et al (2000) Determinants of urinary excretion of Tamm–Horsfall protein in non-selected kidney stone formers and healthy subjects. Nephrol Dial Transplant 15:1580CrossRefPubMed Glauser A, Hochreiter W, Jaeger P et al (2000) Determinants of urinary excretion of Tamm–Horsfall protein in non-selected kidney stone formers and healthy subjects. Nephrol Dial Transplant 15:1580CrossRefPubMed
62.
Zurück zum Zitat Jaggi M, Nakagawa Y, Zipperle L et al (2007) Tamm–Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35:55CrossRefPubMed Jaggi M, Nakagawa Y, Zipperle L et al (2007) Tamm–Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function. Urol Res 35:55CrossRefPubMed
63.
Zurück zum Zitat Hess B, Nakagawa Y, Parks JH et al (1991) Molecular abnormality of Tamm–Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260:F569PubMed Hess B, Nakagawa Y, Parks JH et al (1991) Molecular abnormality of Tamm–Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 260:F569PubMed
64.
Zurück zum Zitat Mo L, Huang HY, Zhu XH et al (2004) Tamm–Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66:1159CrossRefPubMed Mo L, Huang HY, Zhu XH et al (2004) Tamm–Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 66:1159CrossRefPubMed
65.
Zurück zum Zitat Bates JM, Raffi HM, Prasadan K et al (2004) Tamm–Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65:791CrossRefPubMed Bates JM, Raffi HM, Prasadan K et al (2004) Tamm–Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65:791CrossRefPubMed
66.
Zurück zum Zitat Anderson JC, Williams JC Jr, Evan AP et al (2007) Analysis of urinary calculi using an infrared microspectroscopic surface reflectance imaging technique. Urol Res 35:41CrossRefPubMed Anderson JC, Williams JC Jr, Evan AP et al (2007) Analysis of urinary calculi using an infrared microspectroscopic surface reflectance imaging technique. Urol Res 35:41CrossRefPubMed
67.
Zurück zum Zitat Beck L, Karaplis AC, Amizuka N et al (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95:5372CrossRefPubMed Beck L, Karaplis AC, Amizuka N et al (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci USA 95:5372CrossRefPubMed
68.
Zurück zum Zitat Tenenhouse HS, Gauthier C, Martel J et al (2002) Na/P(i) cotransporter (Npt2) gene disruption increases duodenal calcium absorption and expression of epithelial calcium channels 1 and 2. Pflugers Arch 444:670CrossRefPubMed Tenenhouse HS, Gauthier C, Martel J et al (2002) Na/P(i) cotransporter (Npt2) gene disruption increases duodenal calcium absorption and expression of epithelial calcium channels 1 and 2. Pflugers Arch 444:670CrossRefPubMed
69.
Zurück zum Zitat Chau H, El-Maadawy S, McKee MD et al (2003) Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 18:644CrossRefPubMed Chau H, El-Maadawy S, McKee MD et al (2003) Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 18:644CrossRefPubMed
Metadaten
Titel
Nephrocalcinosis in animal models with and without stones
verfasst von
Saeed R. Khan
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 6/2010
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0303-4

Weitere Artikel der Ausgabe 6/2010

Urolithiasis 6/2010 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.